Del

I don’t know about either of their deal flows but as somebody in life sciences, I would definitely go life sciences. The amount of innovation going on in the industry right now is insane. You’ll likely have some exposure to technology within life sciences as the industry is moving more and more towards digitizing healthcare. There’s also a huge push to trim some of the fat in the process of bringing new drugs to market to improve or keep margins the same if the US clamps down more regulatory pressure. And that’s another thing, a lot of pressure from the gov’t to reduce drug prices. There’s going to be massive changes in healthcare in our lifetimes.